Translational Development Acquisition Corp. (TDACW) Earnings History
Profitable9 years of earnings data (2017–2025) · Positive TTM net income
Loading earnings history...
Translational Development Acquisition Corp. (TDACW) Earnings Overview
As of June 29, 2026, Translational Development Acquisition Corp. (TDACW) reported trailing twelve-month net income of $6M, reflecting +2384.0% year-over-year growth. The company earned $0.36 per diluted share over the past four quarters.
Looking at the long-term picture, TDACW's 5-year EPS compound annual growth rate (CAGR) stands at +0.5%, reflecting modest earnings expansion. The company achieved its highest annual net income of $6M in fiscal 2025, representing a new all-time high.
Translational Development Acquisition Corp. maintains positive profitability with. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including BRTX (-$11M net income, -3959.4% margin), HCAI (N/A net income, -659.2% margin), IQV ($1.39B net income, 8.3% margin), TDACW has comparable earnings metrics. Compare TDACW vs BRTX →
TDACW Earnings vs Peers
Earnings metrics vs comparable public companies
TDACW Historical Earnings Data (2017–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6M | +9059.7% | $-944,538 | $0.37 | - | - |
| 2024 | $-71,012 | +85.4% | $-196,358 | $-0.02 | -6.7% | -18.4% |
| 2023 | $-485,550 | -587.1% | $-485,550 | $-0.12 | - | - |
| 2022 | $-70,662 | +94.3% | $-70,662 | $-0.02 | - | - |
| 2020 | -$1M | -149.1% | -$1M | $-0.17 | - | - |
| 2019 | $3M | +80.4% | -$1M | $0.36 | - | - |
| 2018 | $1M | +362912.1% | $-699,334 | $0.24 | - | - |
| 2017 | $-387 | - | $-387 | $-0.00 | - | - |
Download Data
Export TDACW earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TDACW — Frequently Asked Questions
Quick answers to the most common questions about buying TDACW stock.
What is TDACW earnings per share (EPS)?
TDACW trailing twelve-month (TTM) diluted EPS is $0.36, reflecting +2384.0% year-over-year growth. The 5-year EPS CAGR is +0.5%. Complete EPS history from 2017 to 2025 is available in the table on this page.
What is Translational Development Acquisition Corp.'s net income?
Translational Development Acquisition Corp. (TDACW) trailing twelve-month net income is $6M as of 2025. Earnings grew +2384.0% year-over-year.
Is TDACW profitable?
Yes, TDACW is profitable with a TTM net income of $6M and a net profit margin of N/A.
What is TDACW's earnings growth rate?
TDACW compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: +0.5%, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2017 to 2025.
What are TDACW's profit margins?
Translational Development Acquisition Corp. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is +3.7%.
Is TDACW growing earnings?
Yes, TDACW earnings are accelerating — EPS growth of +2384.0% exceeds the 5-year CAGR of +0.5%. TTM net income reached $6M. Earnings momentum is strengthening.
What was TDACW's best earnings year?
Translational Development Acquisition Corp.'s highest annual net income on record is $6M, achieved in fiscal year 2025. Earnings history on this page spans 2017 to 2025 and includes all annual and quarterly figures.
What were TDACW's earnings last quarter?
TDACW's most recent reported quarter was Q1 2026. Net income was $1M with diluted EPS of $0.06. For a full breakdown of all quarters, see the quarterly earnings table on this page.